Toronto Dominion Bank’s Tourmaline Bio TRML Stock Holding History

Toronto Dominion Bank’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-89,200	Closed	-$4.27M	–	2282
2025 Q3	$4.27M	Buy	+89,200	New	+$2.47M	0.01%	839

Toronto Dominion Bank's TRML Position: Q4 2025 in Review

Toronto Dominion Bank sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 89,200 shares — an estimated $4.27M sold.

Toronto Dominion Bank first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $4.27M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Toronto Dominion Bank reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Toronto Dominion Bank sold 89,200 Tourmaline Bio shares in Q4 2025, an estimated $4.27M.
Toronto Dominion Bank first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Toronto Dominion Bank's Tourmaline Bio position peaked at $4.27M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.